Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney disease - Wikidata - wikimedia - TriplyDB

Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney disease

Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney disease

http://www.wikidata.org/entity/Q34281471

about

Lipid abnormalities in kidney disease and management strategies Residual Cardiovascular Risk in Chronic Kidney Disease: Role of High-density Lipoprotein Statins and Renin Angiotensin System Inhibitors Dose-Dependently Protect Hypertensive Patients against Dialysis Risk Association of relatives of hemodialysis patients with metabolic syndrome, albuminuria and Framingham Risk Score.Increased risk of ventricular tachycardia and cardiovascular death in patients with myocarditis during the long-term follow-up: A national representative cohort from the National Health Insurance Research Database.Relation of serum lipids and lipoproteins with progression of CKD: The CRIC study.Serum Non-High-Density Lipoprotein Cholesterol and Risk of Cardiovascular Disease in Community Dwellers with Chronic Kidney Disease: the Hisayama Study Glomerular tip adhesions predict the progression of IgA nephropathy Association of dyslipidemia with renal outcomes in chronic kidney disease.Risks of rapid decline renal function in patients with type 2 diabetes Metabolic syndrome and renal injury Lipid levels and renal function decline in pre-dialysis patients.Serum triglycerides and risk for death in Stage 3 and Stage 4 chronic kidney disease.What's the Optimal Lipids Level for Dialysis Patients? A Cohort Study from a Chinese Dialysis Center in a University Hospital.Cholesterol Metabolism in CKD CKD, plasma lipids, and common carotid intima-media thickness: results from the multi-ethnic study of atherosclerosis.Risk factors of gender for renal progression in patients with early chronic kidney disease.Lipidomic Signature of Progression of Chronic Kidney Disease in the Chronic Renal Insufficiency Cohort.Peripheral arterial stiffness is independently associated with a rapid decline in estimated glomerular filtration rate in patients with type 2 diabetes Statin therapy for preventing cardiovascular diseases in patients treated with tacrolimus after kidney transplantation.Dyslipidemia and risk of renal replacement therapy or death in incident pre-dialysis patients.

P2860

Q27024982-A7F05EAF-B33F-4EB2-BFC8-B21489A597A5 Q28083619-EA6ED269-7C45-472A-9744-884B67E3CBE3 Q28554193-111E1DDD-1EFD-4307-A15E-1215883E0AAC Q33577804-035C7248-D9D6-40E8-8F3F-B6CD7A766461 Q33644095-2ACB935B-D7A0-4B18-83C2-9DD6BC5855EF Q33835707-265D14E9-B9A8-4F0C-99E5-067FE423F3B6 Q33918753-951A91F6-DDC2-4B3E-84F2-A1ABF49AAF2D Q34524136-EEDC726C-9F6A-45C8-B002-EBD8975F6033 Q34580123-8EDDF55A-3F1E-4532-ADF1-B135D6CF7FAE Q34699197-5A54BEE7-1E5E-49D4-B4D5-10BF7CDDCE0E Q34725449-FE74F86C-AA8A-4FF2-BF50-BCA5277ABE67 Q35204390-A449904E-7FDC-4FEE-BA62-30C0F9EFD620 Q36129870-CE9F54AE-2758-4CF2-B2D1-459D70F89464 Q36228385-6CE5638A-0C9C-421B-B46C-CBD64F4C5F7C Q36315574-E4A319B1-2E38-4F5E-8B92-8247F8774BAA Q36371060-24AA3EB4-B3CF-4699-AF7C-E525BA0AD46A Q37605595-CCF97A8F-A317-4FB7-9274-D5AA81A26F23 Q40224049-3D1B733A-14A1-4E4D-98A6-1CF23CDB3EEB Q41771923-D75467AA-1DBC-4F9A-A465-94A59C7F1818 Q47106229-3021A71C-C708-4DAD-B4FF-6FD3F450B832 Q49959013-A5DA3E6A-D124-4B7D-95F4-1113EE1F96C3

P2860

Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney disease

http://www.wikidata.org/entity/Q34281471

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney disease

@ast

Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney disease

@en

Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney disease

@nl

type

label

Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney disease

@ast

Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney disease

@en

Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney disease

@nl

prefLabel

Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney disease

@ast

Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney disease

@en

Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney disease

@nl

P1433

Q34281471-83007C1C-9BBD-4B55-AB1E-1C303697A82F

P1476

Q34281471-C4E087E5-CD21-4E4E-82C2-8AADA9107936

P2093

Q34281471-26DEA79B-5930-467D-A5D6-99DEE755A458

Q34281471-36B0D599-66FA-4F6B-9BA8-66F6D11708EA

Q34281471-7B86C6B2-B8DA-45CF-A7C9-D318977D2756

Q34281471-D0254F75-0CC9-491C-B7C7-0FC9C2EE3795

Q34281471-D21ABCC2-D562-4FF2-B605-80A85FF07337

Q34281471-E46C9B20-8C3C-4238-A4F0-15A31898E92D

Q34281471-F32495EB-636A-420B-8C04-CA47369711DF

P2860

Q34281471-089919BB-B79E-4A56-9F8A-CFC9E95D3621

Q34281471-18061737-F1A8-4F6B-81AE-DBC9D55265F0

Q34281471-20A13293-76BD-4E33-8F44-B04328B7E639

Q34281471-378175CD-76DA-4E6A-A99D-45552D3426D9

Q34281471-4B0F67B0-FA78-4C78-BACB-065A3CA5B42D

Q34281471-71C69BF2-4840-4B66-9424-71E9B43AF132

Q34281471-8A359529-71ED-4FAA-B8C7-D2956F0300EC

Q34281471-8B85FF94-C02E-47BE-8B9B-07561A8A1FE8

Q34281471-8EDDD139-4B36-47C6-897F-A869F42230AD

Q34281471-8F25EFE1-8267-4D74-8440-A32A6C13D43E

P304

Q34281471-A6743004-2D14-4170-B0BC-5FB64510192F

P31

Q34281471-81E212E0-1A92-4540-83E7-854A60A2BF3E

P356

Q34281471-61255F63-B184-4911-A56F-9578CF459849

P433

Q34281471-C07EE0D4-0B14-4DDA-8C50-B6D6462AA852

P478

Q34281471-F47ECC4C-FBF1-4471-A58F-C481FB92677D

P577

Q34281471-73B1FE19-BC38-4EAD-AB8B-F62B1405CC64

P698

Q34281471-93537402-18B6-472E-B091-C59CFA1C68E7

P921

Q34281471-EB84045D-AB10-4CDF-AB75-F02ABC8B25A3

P932

Q34281471-ECB2942A-BA09-479B-B54A-2704AB0709CB

P356

P1433

Clinical Journal of the American Society of Nephrology

P1476

Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney disease

@en

P2093

Allan J Collins

http://www.w3.org/2001/XMLSchema#string

Gerald J Beck

http://www.w3.org/2001/XMLSchema#string

John W Kusek

http://www.w3.org/2001/XMLSchema#string

Mark J Sarnak

http://www.w3.org/2001/XMLSchema#string

Tom Greene

http://www.w3.org/2001/XMLSchema#string

Vandana Menon

http://www.w3.org/2001/XMLSchema#string

Varun Chawla

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths.

Non-lipid-related effects of statins.

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi

Epidemiology of cardiovascular disease in chronic renal disease.

Epidemiology of cardiovascular risk factors in chronic renal disease.

Statin therapy in kidney disease populations: potential benefits beyond lipid lowering and the need for clinical trials.

Sudden cardiac death and dialysis patients.

Association between serum lipids and survival in hemodialysis patients and impact of race.

P304

1582-1587

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.01450210

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2010-06-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20558558

http://www.w3.org/2001/XMLSchema#string

P921

P932

2974397

http://www.w3.org/2001/XMLSchema#string